首页> 中文期刊> 《中国医药指南》 >雾化疗法应用于小儿支气管肺炎的临床应用价值分析

雾化疗法应用于小儿支气管肺炎的临床应用价值分析

         

摘要

Objective Observation on the efifcacy of oxygen drive aemsol adn inistration in the treatment of Children with bronchial pneumonia.Methods 101 Children with bronchial pneumonia in our hospital were selected during January 2013 to January 2014 divided into two groups. Two groups of patients were given the same symptomatic treatment. Control group (51 cases) used expectorant, and asthma treatment. Observation group(50 cases) used Ambroxol Intravenous drip. Observation group depended on the Control group add oxygen drive aemsol adn inistration, observation breathing rate, Oxygen saturation. Results After treatment Observation group was better than the Control group, the difference was statistically signiifcant (P<0.05).Conclusion The efifcacy of drive aemsol adn inistration in the treatment of Children with bronchial pneumonia was well, is worth popularizing in clinical.%目的:探讨雾化疗法应用于小儿支气管肺炎的临床应用价值分析。方法选取2013年1月至2014年1月,到我院就诊的小儿支气管肺炎患者101例,随机分为试验组(51例)与对照组(50例),两组患者均给予相同的对症治疗,对照组使用氨溴索静脉滴注,试验组采用对照组的基础上使用布地奈德雾化吸入,观察两组患者呼吸频率以及氧饱和度等指标的改变。结果治疗后试验组呼吸频率以及氧饱和度指标优于对照组,差异有统计学意义(P<0.05)。结论使用雾化疗法治疗小儿支气管肺炎临床效果显著,值得在临床推广。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号